Z-0107-2026 Class II Ongoing
FDA device recall Z-0107-2026 was initiated by Inpeco S.A. on Sep 3, 2025 and is designated Class II. Reason for recall: The FlexLab X System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and… The recall status is ongoing. Affected quantity: 1 unit.
Recall details
- Product Type
- Devices
- Report Date
- Oct 15, 2025
- Initiation Date
- Sep 3, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 unit
Product description
FlexLab X (FXX) System. Potassium Test System. in vitro diagnostic
Reason for recall
The FlexLab X System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.
Distribution pattern
US distribution to CA & NY.
Code information
PN: FLX-056-40; UDI: 07640172344002: Serial No. FXX.0015.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0107-2026
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Inpeco S.A.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.